Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pacific Islands | 24 | 2025 | 123 | 1.800 |
Why?
|
| Delivery of Health Care | 10 | 2019 | 310 | 1.790 |
Why?
|
| Neoplasms | 17 | 2019 | 1377 | 1.770 |
Why?
|
| Micronesia | 25 | 2026 | 90 | 1.380 |
Why?
|
| Ships | 2 | 2021 | 9 | 1.350 |
Why?
|
| Health Policy | 6 | 2023 | 184 | 1.330 |
Why?
|
| Early Detection of Cancer | 5 | 2025 | 449 | 1.320 |
Why?
|
| Capacity Building | 3 | 2024 | 99 | 1.130 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2025 | 367 | 1.030 |
Why?
|
| Health Surveys | 6 | 2004 | 405 | 0.850 |
Why?
|
| Health Promotion | 4 | 2015 | 704 | 0.830 |
Why?
|
| Humans | 70 | 2026 | 43102 | 0.820 |
Why?
|
| Cocos | 1 | 2023 | 2 | 0.800 |
Why?
|
| Health Status Disparities | 5 | 2020 | 719 | 0.790 |
Why?
|
| Cancer Care Facilities | 2 | 2019 | 20 | 0.780 |
Why?
|
| United States | 20 | 2025 | 5205 | 0.760 |
Why?
|
| Hawaii | 21 | 2024 | 2011 | 0.750 |
Why?
|
| Mass Screening | 3 | 2025 | 541 | 0.740 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 83 | 0.710 |
Why?
|
| Regional Health Planning | 4 | 2004 | 14 | 0.710 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 88 | 0.710 |
Why?
|
| Transients and Migrants | 1 | 2021 | 42 | 0.690 |
Why?
|
| Curriculum | 6 | 2010 | 318 | 0.680 |
Why?
|
| Food Supply | 2 | 2015 | 122 | 0.650 |
Why?
|
| Universities | 3 | 2024 | 559 | 0.630 |
Why?
|
| Papillomavirus Infections | 2 | 2024 | 376 | 0.630 |
Why?
|
| Areca | 2 | 2017 | 33 | 0.630 |
Why?
|
| Health Status | 5 | 2011 | 442 | 0.630 |
Why?
|
| Renal Dialysis | 1 | 2020 | 131 | 0.590 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 706 | 0.580 |
Why?
|
| Nuclear Weapons | 2 | 2010 | 2 | 0.580 |
Why?
|
| Guam | 6 | 2024 | 83 | 0.560 |
Why?
|
| Mastication | 1 | 2017 | 24 | 0.540 |
Why?
|
| Education, Continuing | 2 | 2007 | 18 | 0.520 |
Why?
|
| International Cooperation | 4 | 2019 | 52 | 0.510 |
Why?
|
| Environmental Exposure | 2 | 2010 | 256 | 0.480 |
Why?
|
| Feeding Behavior | 3 | 2006 | 469 | 0.470 |
Why?
|
| Registries | 4 | 2024 | 437 | 0.460 |
Why?
|
| Needs Assessment | 6 | 2007 | 178 | 0.450 |
Why?
|
| Communicable Disease Control | 1 | 2015 | 38 | 0.450 |
Why?
|
| Politics | 3 | 2011 | 42 | 0.440 |
Why?
|
| Public Health Informatics | 2 | 2004 | 9 | 0.440 |
Why?
|
| Health Personnel | 2 | 2007 | 277 | 0.420 |
Why?
|
| Cooperative Behavior | 3 | 2011 | 269 | 0.410 |
Why?
|
| Mouth Neoplasms | 3 | 2020 | 60 | 0.390 |
Why?
|
| Obesity | 4 | 2017 | 1151 | 0.390 |
Why?
|
| History, 21st Century | 5 | 2020 | 83 | 0.380 |
Why?
|
| Health Education | 3 | 2019 | 363 | 0.380 |
Why?
|
| History, 20th Century | 5 | 2020 | 121 | 0.380 |
Why?
|
| Cultural Diversity | 3 | 2003 | 193 | 0.370 |
Why?
|
| Program Evaluation | 2 | 2011 | 359 | 0.360 |
Why?
|
| Vitamin A Deficiency | 4 | 2004 | 13 | 0.350 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 590 | 0.340 |
Why?
|
| Staff Development | 2 | 2007 | 30 | 0.320 |
Why?
|
| Public Health | 3 | 2010 | 424 | 0.320 |
Why?
|
| Health Care Reform | 1 | 2010 | 36 | 0.320 |
Why?
|
| Prevalence | 8 | 2025 | 1612 | 0.320 |
Why?
|
| Health Services | 2 | 2019 | 61 | 0.310 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2007 | 22 | 0.310 |
Why?
|
| Education, Distance | 1 | 2010 | 46 | 0.310 |
Why?
|
| Social Welfare | 4 | 2021 | 29 | 0.310 |
Why?
|
| Cultural Competency | 1 | 2010 | 138 | 0.290 |
Why?
|
| Exercise | 1 | 2015 | 692 | 0.290 |
Why?
|
| Female | 22 | 2025 | 24698 | 0.290 |
Why?
|
| Clinical Competence | 2 | 2007 | 156 | 0.280 |
Why?
|
| Comprehensive Health Care | 2 | 2010 | 11 | 0.270 |
Why?
|
| Health Behavior | 4 | 2017 | 575 | 0.270 |
Why?
|
| Treatment Outcome | 1 | 2011 | 1604 | 0.260 |
Why?
|
| Smoking | 3 | 2014 | 1024 | 0.250 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2007 | 989 | 0.250 |
Why?
|
| Social Marketing | 1 | 2006 | 25 | 0.250 |
Why?
|
| Commerce | 1 | 2007 | 95 | 0.250 |
Why?
|
| Adult | 12 | 2025 | 13872 | 0.250 |
Why?
|
| Anemia | 2 | 2004 | 55 | 0.250 |
Why?
|
| Food Services | 1 | 2006 | 33 | 0.240 |
Why?
|
| Nutritional Status | 3 | 2004 | 119 | 0.240 |
Why?
|
| General Surgery | 1 | 2026 | 28 | 0.240 |
Why?
|
| Surgical Procedures, Operative | 1 | 2026 | 33 | 0.240 |
Why?
|
| Family Practice | 3 | 2003 | 60 | 0.230 |
Why?
|
| Health Services, Indigenous | 2 | 2006 | 33 | 0.230 |
Why?
|
| Professional Competence | 2 | 2002 | 42 | 0.220 |
Why?
|
| Ciguatera Poisoning | 3 | 2003 | 6 | 0.210 |
Why?
|
| Male | 18 | 2025 | 23409 | 0.210 |
Why?
|
| Vaginal Smears | 1 | 2024 | 63 | 0.210 |
Why?
|
| Ethics, Research | 1 | 2024 | 18 | 0.210 |
Why?
|
| Environment | 2 | 2017 | 149 | 0.200 |
Why?
|
| American Samoa | 1 | 2023 | 18 | 0.200 |
Why?
|
| Biomedical Research | 3 | 2019 | 502 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 1 | 2024 | 179 | 0.200 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 374 | 0.200 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 1723 | 0.200 |
Why?
|
| Attitude to Health | 2 | 2004 | 338 | 0.190 |
Why?
|
| Schools | 1 | 2004 | 283 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2023 | 259 | 0.180 |
Why?
|
| Health Services Research | 1 | 2002 | 161 | 0.180 |
Why?
|
| Risk Factors | 5 | 2017 | 3994 | 0.170 |
Why?
|
| Models, Psychological | 1 | 2001 | 140 | 0.170 |
Why?
|
| Child | 8 | 2019 | 3443 | 0.170 |
Why?
|
| Food | 1 | 2001 | 103 | 0.160 |
Why?
|
| Health Expenditures | 1 | 2001 | 44 | 0.160 |
Why?
|
| Public Health Administration | 3 | 2004 | 26 | 0.160 |
Why?
|
| Mannitol | 2 | 1992 | 11 | 0.160 |
Why?
|
| Middle Aged | 9 | 2025 | 12222 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2001 | 148 | 0.160 |
Why?
|
| Community-Based Participatory Research | 1 | 2024 | 352 | 0.160 |
Why?
|
| Adolescent | 6 | 2017 | 6081 | 0.150 |
Why?
|
| Fishes | 2 | 1992 | 73 | 0.150 |
Why?
|
| Infant | 6 | 2006 | 1175 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 512 | 0.150 |
Why?
|
| Program Development | 3 | 2011 | 240 | 0.150 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1999 | 95 | 0.140 |
Why?
|
| Child, Preschool | 6 | 2004 | 1546 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 242 | 0.140 |
Why?
|
| Nuts | 1 | 2017 | 10 | 0.140 |
Why?
|
| Education, Medical, Graduate | 3 | 2003 | 61 | 0.130 |
Why?
|
| Mass Media | 2 | 2007 | 39 | 0.130 |
Why?
|
| Risk | 1 | 2017 | 287 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2014 | 760 | 0.130 |
Why?
|
| Diet | 1 | 2003 | 826 | 0.130 |
Why?
|
| Aged | 7 | 2025 | 8214 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 138 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 1857 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2001 | 539 | 0.120 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 3156 | 0.110 |
Why?
|
| Life Style | 1 | 2017 | 334 | 0.110 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 1234 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 83 | 0.100 |
Why?
|
| Residence Characteristics | 2 | 2020 | 363 | 0.100 |
Why?
|
| Vitamin A | 3 | 2004 | 86 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 760 | 0.100 |
Why?
|
| Medically Underserved Area | 2 | 2004 | 120 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 2853 | 0.100 |
Why?
|
| Incidence | 3 | 2024 | 1078 | 0.100 |
Why?
|
| Comorbidity | 3 | 2010 | 737 | 0.090 |
Why?
|
| Developing Countries | 2 | 2004 | 113 | 0.090 |
Why?
|
| Education, Medical | 2 | 2005 | 118 | 0.090 |
Why?
|
| Syphilis | 1 | 1992 | 24 | 0.090 |
Why?
|
| Geography | 1 | 2011 | 110 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2004 | 972 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 1992 | 175 | 0.080 |
Why?
|
| Health Care Coalitions | 1 | 2010 | 11 | 0.080 |
Why?
|
| Health Plan Implementation | 2 | 2010 | 14 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 165 | 0.080 |
Why?
|
| Federal Government | 1 | 2010 | 7 | 0.080 |
Why?
|
| Social Conditions | 1 | 2010 | 13 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2010 | 50 | 0.080 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2010 | 12 | 0.080 |
Why?
|
| Public Policy | 1 | 2010 | 36 | 0.080 |
Why?
|
| Government Regulation | 1 | 2010 | 15 | 0.080 |
Why?
|
| Emigration and Immigration | 1 | 2010 | 85 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2004 | 863 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2003 | 146 | 0.080 |
Why?
|
| Young Adult | 3 | 2025 | 5080 | 0.080 |
Why?
|
| Psychometrics | 1 | 2011 | 358 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 2 | 2003 | 74 | 0.070 |
Why?
|
| Marine Toxins | 1 | 1988 | 17 | 0.070 |
Why?
|
| Washington | 1 | 2007 | 38 | 0.070 |
Why?
|
| Radiation Monitoring | 1 | 2007 | 9 | 0.060 |
Why?
|
| Age Factors | 2 | 2014 | 1154 | 0.060 |
Why?
|
| Models, Educational | 1 | 2007 | 46 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2004 | 20 | 0.060 |
Why?
|
| Hemoglobins | 2 | 2004 | 113 | 0.060 |
Why?
|
| Ferritins | 2 | 2004 | 63 | 0.060 |
Why?
|
| Data Collection | 1 | 2007 | 210 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 263 | 0.060 |
Why?
|
| Population Groups | 1 | 2006 | 59 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2006 | 33 | 0.060 |
Why?
|
| Consumer Advocacy | 1 | 2006 | 15 | 0.060 |
Why?
|
| Health Resources | 1 | 2006 | 37 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2006 | 63 | 0.060 |
Why?
|
| Cause of Death | 1 | 2006 | 186 | 0.060 |
Why?
|
| Educational Status | 1 | 2007 | 339 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 76 | 0.060 |
Why?
|
| Health Planning Guidelines | 1 | 2004 | 7 | 0.060 |
Why?
|
| Awareness | 1 | 2004 | 73 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1285 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2005 | 246 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2004 | 120 | 0.050 |
Why?
|
| Carotenoids | 1 | 2004 | 74 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Ciguatoxins | 1 | 2003 | 3 | 0.050 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2003 | 8 | 0.050 |
Why?
|
| Hepatitis B | 1 | 2003 | 41 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2002 | 111 | 0.050 |
Why?
|
| Geriatrics | 1 | 2003 | 67 | 0.050 |
Why?
|
| Area Health Education Centers | 1 | 2002 | 5 | 0.050 |
Why?
|
| Research Personnel | 1 | 2024 | 206 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2002 | 90 | 0.050 |
Why?
|
| Body Constitution | 1 | 2001 | 10 | 0.050 |
Why?
|
| Medicine, Traditional | 1 | 2001 | 23 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2001 | 11 | 0.040 |
Why?
|
| Psychology | 1 | 2001 | 39 | 0.040 |
Why?
|
| Retinol-Binding Proteins | 1 | 2001 | 7 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2001 | 128 | 0.040 |
Why?
|
| Food Preferences | 1 | 2001 | 73 | 0.040 |
Why?
|
| Iron | 1 | 2003 | 251 | 0.040 |
Why?
|
| Child Nutrition Disorders | 1 | 2001 | 10 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2001 | 117 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2004 | 457 | 0.040 |
Why?
|
| Lipids | 1 | 2003 | 256 | 0.040 |
Why?
|
| Sex Factors | 1 | 2004 | 1028 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 1992 | 53 | 0.040 |
Why?
|
| Antioxidants | 1 | 2004 | 443 | 0.040 |
Why?
|
| Social Environment | 1 | 2001 | 218 | 0.040 |
Why?
|
| Rural Population | 1 | 2003 | 373 | 0.040 |
Why?
|
| International Agencies | 1 | 2019 | 6 | 0.040 |
Why?
|
| Papua New Guinea | 1 | 2019 | 21 | 0.040 |
Why?
|
| West Indies | 1 | 2019 | 13 | 0.040 |
Why?
|
| United Nations | 1 | 2019 | 5 | 0.040 |
Why?
|
| Organizations | 1 | 2019 | 8 | 0.040 |
Why?
|
| Communication | 1 | 2001 | 210 | 0.040 |
Why?
|
| Palliative Care | 1 | 2019 | 61 | 0.040 |
Why?
|
| Inflammation | 1 | 2004 | 758 | 0.040 |
Why?
|
| Forecasting | 1 | 2019 | 136 | 0.040 |
Why?
|
| Resilience, Psychological | 1 | 2020 | 106 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2001 | 925 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2019 | 219 | 0.030 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 10 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2001 | 661 | 0.030 |
Why?
|
| Alphapapillomavirus | 1 | 2014 | 31 | 0.030 |
Why?
|
| Dental Care | 1 | 2014 | 41 | 0.030 |
Why?
|
| Oral Health | 1 | 2014 | 87 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 186 | 0.020 |
Why?
|
| Yaws | 1 | 1992 | 1 | 0.020 |
Why?
|
| Hemagglutination Tests | 1 | 1992 | 4 | 0.020 |
Why?
|
| Syphilis Serodiagnosis | 1 | 1992 | 7 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2004 | 638 | 0.020 |
Why?
|
| Social Class | 1 | 2014 | 291 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 50 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 50 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 609 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2010 | 145 | 0.020 |
Why?
|
| Recurrence | 1 | 1988 | 152 | 0.020 |
Why?
|
| Animals | 3 | 2003 | 16992 | 0.020 |
Why?
|
| New Zealand | 1 | 2006 | 32 | 0.020 |
Why?
|
| Australia | 1 | 2006 | 103 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2005 | 11 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2006 | 65 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2006 | 72 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2005 | 89 | 0.010 |
Why?
|
| Income | 1 | 2006 | 160 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 74 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 18 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 162 | 0.010 |
Why?
|
| beta Carotene | 1 | 2004 | 11 | 0.010 |
Why?
|
| Lutein | 1 | 2004 | 6 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 7 | 0.010 |
Why?
|
| Xanthophylls | 1 | 2004 | 21 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 317 | 0.010 |
Why?
|
| Child Welfare | 1 | 2004 | 49 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 587 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 155 | 0.010 |
Why?
|
| Palau | 1 | 2002 | 9 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 157 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2003 | 136 | 0.010 |
Why?
|
| Leadership | 1 | 2002 | 86 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 2001 | 15 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2001 | 70 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2001 | 39 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 306 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2001 | 80 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 549 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 652 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 945 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 611 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2676 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 6644 | 0.010 |
Why?
|